Oncimmune Holdings (UK) Market Value

ONC Stock   1.14  0.05  4.20%   
Oncimmune Holdings' market value is the price at which a share of Oncimmune Holdings trades on a public exchange. It measures the collective expectations of Oncimmune Holdings plc investors about its performance. Oncimmune Holdings is trading at 1.14 as of the 16th of March 2025, a 4.2 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.08.
With this module, you can estimate the performance of a buy and hold strategy of Oncimmune Holdings plc and determine expected loss or profit from investing in Oncimmune Holdings over a given investment horizon. Check out Oncimmune Holdings Correlation, Oncimmune Holdings Volatility and Oncimmune Holdings Alpha and Beta module to complement your research on Oncimmune Holdings.
Symbol

Please note, there is a significant difference between Oncimmune Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncimmune Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncimmune Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Oncimmune Holdings 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncimmune Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncimmune Holdings.
0.00
12/16/2024
No Change 0.00  0.0 
In 2 months and 31 days
03/16/2025
0.00
If you would invest  0.00  in Oncimmune Holdings on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Oncimmune Holdings plc or generate 0.0% return on investment in Oncimmune Holdings over 90 days. Oncimmune Holdings is related to or competes with Gaztransport, Empire Metals, Rheinmetall, JD Sports, AMG Advanced, CNH Industrial, and Critical Metals. Oncimmune Holdings is entity of United Kingdom More

Oncimmune Holdings Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncimmune Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oncimmune Holdings plc upside and downside potential and time the market with a certain degree of confidence.

Oncimmune Holdings Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncimmune Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncimmune Holdings' standard deviation. In reality, there are many statistical measures that can use Oncimmune Holdings historical prices to predict the future Oncimmune Holdings' volatility.
Hype
Prediction
LowEstimatedHigh
0.040.8811.47
Details
Intrinsic
Valuation
LowRealHigh
0.051.0911.68
Details
Naive
Forecast
LowNextHigh
0.042.1512.74
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.7-2.7-2.7
Details

Oncimmune Holdings plc Backtested Returns

Oncimmune Holdings plc maintains Sharpe Ratio (i.e., Efficiency) of -0.33, which implies the firm had a -0.33 % return per unit of risk over the last 3 months. Oncimmune Holdings plc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncimmune Holdings' Risk Adjusted Performance of (0.27), variance of 107.63, and Coefficient Of Variation of (315.64) to confirm the risk estimate we provide. The company holds a Beta of -1.62, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Oncimmune Holdings are expected to decrease by larger amounts. On the other hand, during market turmoil, Oncimmune Holdings is expected to outperform it. At this point, Oncimmune Holdings plc has a negative expected return of -3.45%. Please make sure to check Oncimmune Holdings' standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if Oncimmune Holdings plc performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.93  

Excellent predictability

Oncimmune Holdings plc has excellent predictability. Overlapping area represents the amount of predictability between Oncimmune Holdings time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oncimmune Holdings plc price movement. The serial correlation of 0.93 indicates that approximately 93.0% of current Oncimmune Holdings price fluctuation can be explain by its past prices.
Correlation Coefficient0.93
Spearman Rank Test0.94
Residual Average0.0
Price Variance12.18

Oncimmune Holdings plc lagged returns against current returns

Autocorrelation, which is Oncimmune Holdings stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oncimmune Holdings' stock expected returns. We can calculate the autocorrelation of Oncimmune Holdings returns to help us make a trade decision. For example, suppose you find that Oncimmune Holdings has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Oncimmune Holdings regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oncimmune Holdings stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oncimmune Holdings stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oncimmune Holdings stock over time.
   Current vs Lagged Prices   
       Timeline  

Oncimmune Holdings Lagged Returns

When evaluating Oncimmune Holdings' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oncimmune Holdings stock have on its future price. Oncimmune Holdings autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oncimmune Holdings autocorrelation shows the relationship between Oncimmune Holdings stock current value and its past values and can show if there is a momentum factor associated with investing in Oncimmune Holdings plc.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Oncimmune Stock

Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.